ADARx Pharmaceuticals, Inc.
ADARx Pharmaceuticals, Inc. is a company that develops RNA medicines leveraging RNA science and proprietary targeted delivery platforms to silence the underlying cause of disease.
Funding history
About ADARx Pharmaceuticals, Inc.
How much funding has ADARx Pharmaceuticals, Inc. raised?
ADARx Pharmaceuticals, Inc. has raised $200.0M in total funding. The most recent round was Series C.
Where is ADARx Pharmaceuticals, Inc. headquartered?
ADARx Pharmaceuticals, Inc. is headquartered in San Diego, CA.
What does ADARx Pharmaceuticals, Inc. do?
ADARx Pharmaceuticals, Inc. is a company that develops RNA medicines leveraging RNA science and proprietary targeted delivery platforms to silence the underlying cause of disease.
What problem does ADARx Pharmaceuticals, Inc. solve?
Unmet treatment needs across genetic, complement-mediated, cardiovascular, cardiometabolic, CNS, and metabolic chronic diseases where other treatment modalities fall short.
What's ADARx Pharmaceuticals, Inc.'s solution?
ADARx develops a pipeline of RNA medicines using its RNA science expertise and proprietary targeted delivery platforms to precisely silence the underlying cause of disease.
What makes ADARx Pharmaceuticals, Inc. different?
The company points to proprietary targeted delivery platforms and RNA medicines designed for improved potency, precision, and durability compared to other treatment modalities.
What makes ADARx Pharmaceuticals, Inc. notable?
Has raised over $350 million from major healthcare investors including OrbiMed, BlackRock, and Bain Capital Life Sciences.
Leadership
Related terms
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated September 3, 2026.
🏷 Embed this badge
Building or fundraising? Add this to your site to show you're listed on SoCal.Startups — the link back helps other founders and investors find you here too.
